1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Svenningsson, Per ; Odin, Per LU ; Dizdar, Nil ; Johansson, Anders ; Grigoriou, Sotirios LU
; Tsitsi, Panagiota
; Wictorin, Klas
LU
; Bergquist, Filip
; Nyholm, Dag
LU
and Rinne, Juha
, et al.
(2020)
In Movement Disorders
35(6).
p.1046-1054
Mark
- 2018
- Dopaminergic effect on non-motor symptoms in late stage Parkinson's disease
- 2015
- Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
- Rating Apathy in Huntington’s Disease : Patients and Companions Agree